Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update of treatment for Gaucher disease
Weijing Kong, Cheng Lu, Yingxue Ding, et al.
European Journal of Pharmacology (2022) Vol. 926, pp. 175023-175023
Closed Access | Times Cited: 23

Showing 23 citing articles:

Challenges in Gaucher disease: Perspectives from an expert panel
Gregory A. Grabowski, Priya S. Kishnani, Roy N. Alcalay, et al.
Molecular Genetics and Metabolism (2025), pp. 109074-109074
Closed Access | Times Cited: 1
A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach
Shunping Feng, Nino Rcheulishvili, Xiaoming Jiang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2111-2129
Open Access | Times Cited: 6
Neurological symptoms in adults with Gaucher disease: a systematic review
Gabriele Imbalzano, Claudia Ledda, Alberto Romagnolo, et al.
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 3897-3907
Open Access | Times Cited: 5
Targeting lysosomal quality control as a therapeutic strategy against aging and diseases
Yuchen He, Yishu Fan, Xenab Ahmadpoor, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2472-2509
Closed Access | Times Cited: 4
Clinical insights in enzyme replacement therapy for metabolic storage disorders: lessons from Pompe disease
Nadine A. M. E. van der Beek, M. Theunissen, Johanna M. P. van den Hout, et al.
The Lancet Neurology (2025) Vol. 24, Iss. 3, pp. 230-245
Closed Access
Clinical Outcomes and Genetic Mutations in Turkish Patients with Type 1 Gaucher Disease: Insights from a Single-Center Study
Ali Rıza Çalışkan, Jasmin Weninger, Hüseyin KAÇMAZ, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 3, pp. 109-109
Open Access
Spanish consensus on managing pregnancy in women with Gaucher disease
Enrique J. Calderón, Alicia Rodríguez, Irene Calderón-Baturone, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access
Phase 1 Healthy Volunteer Study of AL01211, an Oral, Non‐brain Penetrant Glucosylceramide Synthase Inhibitor, to Treat Fabry Disease and Type 1 Gaucher Disease
M. A. Babcock, Zheng Jian-hong, Jessica Gail Shurr, et al.
Clinical Pharmacology in Drug Development (2024) Vol. 13, Iss. 6, pp. 696-709
Open Access | Times Cited: 3
Multivalent pyrrolidines acting as pharmacological chaperones against Gaucher disease
Marc Borie-Guichot, My Lan Tran, Virginie Garcia, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107295-107295
Closed Access | Times Cited: 3
Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report
Jianhui Zhang, Hui Chen, Dan‐dan Ruan, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1765-1774
Closed Access | Times Cited: 2
Systematic Review of Genetic Substrate Reduction Therapy in Lysosomal Storage Diseases: Opportunities, Challenges and Delivery Systems
Marina Beraza-Millor, Julen Rodríguez-Castejón, Ana del Pozo‐Rodríguez, et al.
BioDrugs (2024) Vol. 38, Iss. 5, pp. 657-680
Open Access | Times Cited: 2
Pediatric Gaucher Disease Presenting with Massive Splenomegaly and Hepatic Gaucheroma
Gianluca Bossù, Laura Pedretti, Lorenzo Bertolini, et al.
Children (2023) Vol. 10, Iss. 5, pp. 869-869
Open Access | Times Cited: 6
Concise Synthesis of 1,4-Dideoxy-1,4-imino-l-arabinitol (LAB) from d-Xylose by Intramolecular Stereospecific Substitution of a Hydroxy Group
Sunisa Akkarasamiyo, Hatairat Promsaka Na Sakonnakhon, Punlop Kuntiyong, et al.
Synlett (2023) Vol. 34, Iss. 05, pp. 441-444
Closed Access | Times Cited: 2
Gaucher Disease Coexisting with Cytomegalovirus Infection: A Rare Presentation in an Infant
Zhaoxia Zhang, Dong Liu, Zhangbin Yu, et al.
American Journal of Case Reports (2024) Vol. 25
Open Access
N‐Methyl‐N‐Alkylaminocyclopentanes: Powerful and Selective β‐d‐Glucocerebrosidase Inhibitors
Patrick Weber, Roland C. Fischer, Seyed A. Nasseri, et al.
Helvetica Chimica Acta (2024) Vol. 107, Iss. 4
Closed Access
Importance of lysosomal storage diseases in rheumatology
Charlotte Aries, Cornelia Rudolph, Nicole Muschol
Zeitschrift für Rheumatologie (2024) Vol. 83, Iss. 5, pp. 393-400
Closed Access
Progressive Thrombocytopenia, Splenomegaly, and Abnormal Tone in an Infant With Growth Faltering
Gal Barak, Gail J. Demmler‐Harrison, Linda Rossetti, et al.
PEDIATRICS (2024) Vol. 154, Iss. 1
Closed Access
Recent Therapeutic Advancements for Gaucher Disease
Lipi Pradhan, Sumit Manna, Pragya Pragya, et al.
Advanced Therapeutics (2024) Vol. 8, Iss. 1
Open Access
UPLC-MS/MS High-Risk Screening for Sphingolipidoses Using Dried Urine Spots
Tristan Martineau, Bruno Maranda, Christiane Auray‐Blais
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1612-1612
Open Access
Current opinion on pluripotent stem cell technology in Gaucher's disease: challenges and future prospects
Pankaj Gurra, Raja Babu, Bhaskaranand Pancholi, et al.
Cytotechnology (2024) Vol. 77, Iss. 1
Closed Access
Gaucher Disease in Internal Medicine and Dentistry
Michele Basilicata, Giulia Marrone, Manuela Di Lauro, et al.
Applied Sciences (2023) Vol. 13, Iss. 6, pp. 4062-4062
Open Access
First Example of Multivalent Pyrrolidines Acting as Pharmacological Chaperones Against Gaucher Disease
Marc Borie-Guichot, My Lan Tran, Virginie Garcia, et al.
(2023)
Closed Access
Doenças de depósito: ocronose, Fabry e Gaucher
Nilton Salles Rosa Neto
Revista Paulista de Reumatologia (2023) Vol. 22, Iss. 2, pp. 38-46
Closed Access
Page 1

Scroll to top